To further characterize MPP ؉ -induced cell death and to explore the role of Bcl-2-related proteins in this death paradigm, we utilized a mesencephalon-derived dopaminergic neuronal cell line (MN9D) stably transfected with human bcl-2 (MN9D/Bcl-2), its C-terminal deletion mutant (MN9D/Bcl-2⌬22), murine bax (MN9D/ Bax), or a control vector (MN9D/Neo). As determined by electron microscopy and TUNEL assay, MN9D/Neo cells exposed to MPP ؉ underwent a cell death that was characterized by mitochondrial swelling and irregularly scattered heterochromatin without accompanying DNA fragmentation. However, cell swelling typically seen in necrosis did not appear. 
INTRODUCTION
Apoptosis and necrosis are two fundamental types of cell death with different morphological features. Apoptosis is characterized by distinctive changes such as cellular shrinkage, cytoplasmic blebbing, and condensation of chromatin while necrosis is defined by mitochondrial swelling, cell swelling, and irregularly scattered heterochromatin. In contrast to necrosis which has been considered a passive degenerative process, apoptosis is a controlled cellular process that, in many cases, can be blocked by inhibitors of RNA and protein synthesis (23) . Cysteine proteases encoded by Caenorhabditis elegans ced-3 and its mammalian homologs, recently termed caspases, appear to play a key role in triggering apoptosis (22) .
Numerous studies have demonstrated that Bcl-2, a 26-kDa integral membrane protein, enhances cell survival by preventing apoptosis and at least some forms of necrosis induced by a wide variety of stimuli (16, 37, 41) . Various biochemical and molecular mechanism(s) utilized by Bcl-2 to prevent cell death have been proposed (43) . For example, the ratio of Bcl-2 to Bax has been proposed to be a critical determinant of cell survival or death following various stimuli (34) . Other experiments have suggested that Bcl-2 represses cell death by regulating the level of cytosolic calcium (2, 18) . Inasmuch as Bcl-2 also blocks caspase cascades acti-vated by cell death signals, it appears that Bcl-2 has multiple independent functions during cell death processes.
Administration of MPTP to nonhuman primates and other animal species causes selective destruction of the nigrostriatal dopaminergic pathway similar to that observed in Parkinson's disease (40) . Its metabolite, MPP ϩ , is a potent inhibitor of mitochondrial NADHlinked electron transport at Complex I resulting in the loss of ATP production and subsequent cell death. A recent study demonstrates that MPTP can elicit apoptotic nuclei in the substantia nigra compacta (39) . However, the type of cell death and its associated mechanisms induced by this neurotoxin are still controversial. For example, although several lines of evidence have indicated that cells treated with MPTP or MPP ϩ exhibit typical apoptotic features, the cell types tested are not neurons nor has it been clearly demonstrated that the cells dying of apoptosis are indeed dopaminergic neurons (6, 13, 14, 26, 36) . In contrast, it has been suggested that intracellular ATP levels determine whether a cell dies by apoptosis or necrosis (8) . Specifically, inhibition of the mitochondrial respiratory chain by rotenone, which, like MPP ϩ , targets Complex I, induces necrotic cell death (37) . This is in agreement with studies demonstrating that no signs of DNA fragmentation are found in tyrosine hydroxylasepositive dopaminergic neurons from MPTP-treated C57/bl mice (15) .
We have used a mesencephalon-derived dopaminergic neuronal cell line, MN9D, for examining cell death (29, (31) (32) (33) . Thus, the specific aims of the present study were to characterize the MPP ϩ -induced cell death in MN9D cells and to investigate the role of Bcl-2-related proteins in this model. Therefore, we set out experiments to investigate morphological changes and biochemical events associated with MPP ϩ -induced neuronal cell death. The possibility that Bcl-2, its C-terminal deletion mutant, or Bax may modulate the MPP ϩ -induced toxicity was also examined.
MATERIALS AND METHODS
Cell culture and drug treatment. Stable MN9D cell lines overexpressing full-length human Bcl-2 (MN9D/ Bcl-2), its C-terminal deletion mutant (MN9D/Bcl-2⌬22), or mouse Bax (MN9D/Bax) were previously established and characterized (31) (32) (33) . Cells from each established cell line were plated at 2 ϫ 10 4 /48-well plate, cultivated in DMEM supplemented with 10% fetal bovine serum and 250 µg/ml G-418 (complete culture medium; CCM) for 3 days, switched to serumfree N2 medium, and treated with 5-100 µM MPP ϩ (Research Biochemicals International) or 1 µM staurosporine (Sigma) for the indicated time periods. If necessary, cells were treated in combination with 0.25-2.0 µg/ml cycloheximide, 0.5-2.0 µg/ml emetine, 0.1-0.4 µM actinomycin D, 50-200 µM Boc-aspartyl(OMe)-fluoromethylketane (BAF; Enzyme Systems Products) or 50-400 µM N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketene (Z-VAD-fmk; Enzyme Systems Products). Following incubation with various experimental reagents, the rate of cell survival was assessed using the MTT reduction assay as described previously (33) . Values from each treatment were expressed as percentage of survival over the untreated control (100% survival).
Electron microscopy. Both MN9D/Neo and MN9D/ Bcl-2 cells plated at a density of 1-2 ϫ 10 5 on poly-Dlysine-coated six-well plates were treated with 5-100 µM MPP ϩ . After various incubation periods, cells were fixed in 2% paraformaldehyde/2% glutaraldehyde in 0.1 M cacodylate buffer (pH 7.4) overnight at 4°C and then postfixed in 1% osmium tetraoxide/1.5% ferrocyanide solution for 30 min at RT. Cells were dehydratd in a graded series of ethanols, embedded in Epon resin, and heat polymerized. Epon blocks were cut using a Reichert-Jung Ultracut S (Leica), double stained with uranyl acetate and lead citrate, and observed under a Zeiss EM 902A electron microscope.
Terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL). To label DNA breaks in individual nuclei, the TUNEL assay was performed on MN9D/Neo cells after treatment with 100 µM MPP ϩ for 12-36 h or 100 µM etoposide for 24 h (positive control). After fixation of cells in 4% paraformaldehyde, proteins associated with DNA were stripped off by incubation with 20 µg/ml proteinase K for 15 min at RT. Endogenous peroxidase was inactivated in 2% hydrogen peroxide for 2 min at RT. Cells were then incubated in terminal deoxynucleotidyl transferase buffer containing digoxigenin-dUTP and terminal transferase for 1 h at 37°C. After termination of the reaction, cells were incubated in peroxidase-conjugated anti-digoxigenin (Oncor) for 30 min at RT, processed for color development using DAB as a substrate, and counterstained in methyl green.
Western blot analysis. For Western blot analysis, approximately 5 ϫ 10 6 cells of MN9D/Neo after 100 µM MPP ϩ treatment for various time intervals were washed with ice-cold PBS and lysed in a buffer containing 50 mM Tris, pH 7.0, 2 mM EDTA, 1% Triton X-100, 2 mM PMSF, 10 µg/ml leupeptin and aprotinin for 10 min. Lysates were centrifuged at 13,000g for 30 min at 4°C. The supernatants were transferred into a new Eppendorf tube and kept at Ϫ70°C until use. Protein content was measured using the Bio-Rad protein assay reagent. Subsequently, 40 µg of protein from each sample was separated on 12.5% SDS-PAGE, blotted onto prewet PVDF-nitrocellulose filters, and further processed for Western blot analysis. Polyclonal anti-Bax was obtained from PharMingen.
Measurement of the level of cytosolic calcium.
[Ca 2ϩ ] i was measured using Fura-2 fluorescence videomicroscopy. Cells for [Ca 2ϩ ] i imaging experiments were plated on 35-mm glass-bottom dishes coated with poly-Dlysine. Cells were loaded with the cytosolic calcium indicator, 5 µM Fura-2/Am plus 0.1% pluronic F-127 for 30 min at RT and incubated for an additional 30 min in Hepes-buffered salt solution. Experiments were performed at RT, on the stage of a Nikon Diaphot inverted microscope equipped with a 75-W xenon lamp and a Nikon 40ϫ, 1.3 N.A. epifluorescence oil immersion objective. Fura-2 (excitation 340, 380 nm; emission 510 nm) ratio images were acquired with an intensified CCD camera (Quantex) and digitized (256 ϫ 512 pixels) using an Image 1 system (Universal Image). Background flourescence from a cell-free region was subtracted from each 340-and 380-nm image. Calibrated values were obtained in situ by determining F min (2 mM EGTA in Ca 2ϩ free-solution) and F max (10 µM ionomycin in 10 mM Ca 2ϩ solution). A K d of 225 nM was used in the ratio method formula.
RESULTS

Morphological characterization of MPP ϩ -induced cell death.
Previously, we have shown that cell death mediated by MPP ϩ treatment in MN9D/Neo cells or MN9D parental cells was not accompanied by known apoptotic changes such as membrane blebbing, nuclear chromatin condensation, and DNA laddering over a wide concentration range (5-100 µM; 33). When morphological features were further analyzed by electron microscopy, MPP ϩ -induced cell death accompanied many necrotic features (Fig. 1) . For example, mitochondrial swelling appeared as early as 10-12 h after 100 µM MPP ϩ treatment (Fig. 1B) . Thereafter, typically necrotic changes such as mitochondrial swelling and irregularly scattered heterochromatin became widespread in the majority of cells (24 h , Fig. 1C ). However, cell swelling typically seen in necrosis was not readily detected even at the later stage of cell death (up to 40 h). As judged by TUNEL staining, no TUNEL-positive nuclei were detected in MPP ϩ -induced cell death up to 36 h whereas many TUNEL-positive nuclei were observed in etoposide-induced apoptotic cell death (Figs. 2B and 2C). This was in good agreement with previous findings that MPP ϩ treatment did not generate internucleosomal DNA fragments (15, 33) . A similar result was observed over a wide concentration range of MPP ϩ but more protracted (5-100 µM; not shown).
Biochemical analysis of MPP ϩ -induced cell death. When MN9D/Neo cells were treated with 100 µM MPP ϩ for 40 h, the majority of cells were dead (Fig. 3A) . Approximately 50% of cells were functionally dead around 24-28 h after treatment as determined by the MTT reduction assay. Cotreatment with a broadspectrum caspase inhibitor, Z-VAD-fmk (50-400 µM) or BAF (up to 200 µM), did not rescue MPP ϩ -induced cell death while Z-VAD-fmk attenuated staurosporineinduced apoptotic cell death, demonstrating that activation of Z-VAD-fmk-or BAF-sensitive caspases typically seen in many apoptotic paradigms was not involved in MPP ϩ -induced cell death (Fig. 3A) . This caspase independency was also observed in a wide concentration range of MPP ϩ (5-100 µM; not shown) . Similarly, MPP ϩ did not induce caspase-mediated cleavage of poly(ADP-ribose)polymerase (not shown). When MN9D/ Neo cells were cotreated with a protein synthesis inhibitor, cycloheximide, MPP ϩ -induced cell death was blocked in a dose-dependent manner, suggesting that new protein synthesis is required in this cell death paradigm (Fig. 3B) . Other inhibitors of macromolecule synthesis such as emetine and actinomycin D completely blocked MPP ϩ -induced cell death as well (Fig.  3B) .
Measurement of transient and long-term changes in cytosolic free calcium after MPP ϩ -treatment. Increased levels of cytosolic calcium over physiological concentrations have been demonstrated to trigger cell death in many cases (11) . To investigate the involvement of cytosolic free calcium with MPP ϩ -induced cell death in MN9D, changes in cytosolic calcium were measured using Fura-2 videomicroscopy. As shown in Fig. 4A , no changes in cytosolic calcium were observed after treatment with 100 µM MPP ϩ for 4, 8, and 24 h. Nor were changes in cytosolic calcium levels detected after continuous monitoring for up to 70 min (Fig. 4B) .
Role of Bax in MPP ϩ -induced cell death. Since it has been proposed that the ratio of Bcl-2 to Bax is a critical determinant of cell survival or death following various stimuli (34), the expression level of a wellknown cell death-associated protein, Bax, was first analyzed following MPP ϩ treatment. As shown in Fig.  5A , no discernible increases in Bax expression were detected for up to 24 h after 100 µM MPP ϩ treatment. During this course of cell death, endogenous Bcl-2 was not detected at all time points, suggesting that a simple ratio relationship between Bcl-2 and Bax is not involved in this cell death paradigm. To directly investigate the involvement of Bax in MPP ϩ -induced cell death, two separate clonal MN9D cells overexpressing murine Bax (MN9D/Bax Nos. 9 and 11; 31) and MN9D/ Neo control cells were treated with 100 µM MPP ϩ for various time periods. As shown in Fig. 5B , the rate of death in MN9D/Bax cells remained virtually unchanged compared to that in MN9D/Neo cells.
Role of Bcl-2 in MPP ϩ -induced cell death. As shown in Fig. 6A , overexpression of Bcl-2 greatly attenuated MPP ϩ -induced cell death (48.4% survival in MN9D/ Bcl-2 vs 11.3% survival in MN9D/Neo cells following MPP ϩ treatment for 48 h). Bcl-2 did not affect the level of cytosolic calcium and Bax expression (not shown). It delayed MPP ϩ -induced morphological changes including mitochondrial swelling at least by 6-8 h as determined by electron microscopy. For example, mitochondrial swelling in MN9D/Bcl-2 cells was less severe than that in MN9D/Neo cells (Figs. 6B and 6C) . We previously found that both MN9D/Bcl-2 and MN9D/Bcl-2⌬22 cells were equally protective in staurosporineinduced apoptotic cell death (32) . However, only 23.9% of MN9D/Bcl-2⌬22 cells survived after MPP ϩ treatment, indicating that the C-terminal membrane anchorage domain of Bcl-2 is important in the MPP ϩ -induced cell death model (Fig. 6A) .
DISCUSSION
In our present study, MPP ϩ appears to induce cell death characterized by mitochondrial swelling and irregularly scattered chromatin without accompanying DNA fragmentation. However, cell swelling typically seen in necrosis does not appear up until the majority of the MPP ϩ -treated cells are dead. Moreover, MPP ϩ -induced cell death is completely blocked in the presence of cycloheximide, emetine, or actinomycin D as demonstrated in many apoptotic cell deaths. Previous reports have suggested that the severity of the insult may influence whether MPP ϩ treatment leads to apoptosis or necrosis in PC12 cells and cerebellar granule neurons (7, 12) . In the present context, this explanation seems unlikely since similar morphological and biochemical changes were observed in MN9D cells following MPP ϩ treatment with a wide concentration range (5-100 µM), indicating that MPP ϩ may induce a distinct form of cell death that has properties resembling both apoptosis and necrosis in our mesencephalonderived dopaminergic neuronal cell line. In this model, we have first demonstrated that MPP ϩ can induce cell death independent of the level of cytosolic calcium, Bax expression, and/or caspase activation. Another interesting finding of our present studies is that full-length Bcl-2 but not C-terminal deletion mutant attenuates MPP ϩ -induced cell death. This indicates that Bcl-2 may act as a death repressor at a point distinct from cytosolic calcium, Bax, and caspase in MN9D cells.
As described, MPP ϩ -induced cell death appears to be an active process depending on new protein synthesis as previously demonstrated in other system (23) . Although very low concentrations (nM ranges) of cycloheximide have been shown to protect neurons against excitotoxic and oxidative insults by a mechanism that apparently involves stimulation of an antioxidant pathway (10), the concentration of cycloheximide (approximately up to 7 µM) used in the present study causes sustained blockade of protein synthesis (76% reduction of protein synthesis over the untreated control MN9D cells in the presence of 1 µg/ml cycloheximide). Furthermore, our observation that MPP ϩ -induced cell death is not rescued in the presence of various antioxidants (N-acetylcysteine, superoxide dismutase mimetic, catalase, soluble form of vitamine E, desferrioxamine or N G -nitro-L-arginine) indicates that a newly synthesized protein(s) is required for induction of MPP ϩ -induced cell death in MN9D cells (30) . This newly synthesized protein(s) may participate in activating or repressing the cell death-associated machinery in MN9D cells. Currently, we are trying to characterize several candidate genes that are either upregulated or induced after MPP ϩ treatment as determined by differential display RT-PCR in our laboratory (Lee et al., unpublished data).
It has been shown that cell death-promoting protein, Bax, is required for both naturally occurring and experimentally induced neuronal cell death. In addition, upregulation of Bax expression has been demonstrated in the neurons of a patient with neurodegenerative disorders and of an experimental animal model (13, 21, 27, 38) . However, the level of Bax is not upregulated during the course of MPP ϩ -induced cell death in MN9D cells. Furthermore, overexpression of Bax in MN9D cells does not affect the kinetics of MPP ϩ -induced cell death. These results are in good agreement with the previous findings demonstrating that a Bax-independent cell death pathway exists in both neuronal and nonneuronal cells (3, 5, 19, 35) . Interestingly, p53 is reported to activate the transcription of bax or downregulate the transcription of bcl-2 as a transcriptional factor by binding to its response element within bax and bcl-2 (25) . From our preliminary data, the expression level of p53, however, remains unchanged, strengthening the possibility that a p53-Bax-cell death loop may not exist in MPP ϩ -induced cell death in MN9D.
It is thought that increasing cytosolic calcium levels over physiological concentrations might trigger neuronal cell death by activating a specific calcium-sensitive biochemical pathway (11) . In fact, mitochondrial damage and the resulting increases in cytosolic calcium levels are proposed to play a key role in the induction of MPP ϩ -mediated cytotoxicity in hepatocytes, fibroblast, neurons, or isolated mitochondria (4, 9, 17, 20, 42) . In MN9D cells, MPP ϩ treatment causes mitochondrial swelling at least by 10-12 h as demonstrated by electron microscopy. This is accompanied with collapse of the mitochondrial membrane potential as determined by rhodamine 123, a cationic fluorophore taken up by mitochondria depending upon the membrane potential (33) . However, increases in cytosolic calcium were not observed in MN9D cells after MPP ϩ treatment as determined by Fura-2. Even though it is highly speculative at present, these data may indicate that loss of mitochondrial membrane potential induced by MPP ϩ treatment does not necessarily lead to increase in the level of cytosolic calcium. MPP ϩ -induced cell death in MN9D cells was not antagonized by cotreatment with nimodifine (not shown). Together with recent evidence by Airaksinen et al. demonstrating that there is no significant difference in the extent of dopaminergic neuronal loss between MPTP-treated calbindin-D-28k (the intracellular calcium-binding protein)-deficient mice and their wild-type littermates (1), our data raise the possibility that the MPP ϩ -induced disturbance of calcium homeostasis, if any, is not directly associated with dopaminergic neuronal cell death. However, our study does not completely rule out the possibility that calcium is still somehow involved in MPP ϩ -induced cell death by an unidentified mechanism(s).
In contrast to our previous data from staurosporineinduced cell death in MN9D cells (32) , the C-terminal membrane anchorage domain of Bcl-2 seems to be essential for protection from MPP ϩ -induced cell death. This finding suggests that the requirement for this structural motif of Bcl-2 may depend upon the type of stress applied. It remains to be determined how the proapoptotic protein, Bcl-2, blocks cell death independently of Bax expression, level of cytosolic calcium, and caspase activation. As we have proposed that the protective effect of Bcl-2 following MPP ϩ treatment is mediated by a reduced rate of glucose uptake (33) , one of the potential sites of Bcl-2 action in MPP ϩ -induced cell death could be at a point downstream of the collapse of cellular energy homeostasis as previously suggested (24) . Given findings that overexpression of Bcl-2 in MN9D cells or in neocortical neurons of transgenic mice partially blocks MPP ϩ -induced cell death (28) , these data suggest that mechanisms independent of Bcl-2 may be involved in MPP ϩ -induced cell death. Further studies using this and other systems could provide insight into mechanisms associated with the pathogenesis of Parkinson's disease as well as tools to evaluate the functional role of the Bcl-2 gene family in dopaminergic neuronal cell death.
